Ambalal Sarabhai Enterprises Ltd

NSE: AMBALALSA · BSE: 500009 · Pharmaceuticals & Biotechnology · 15 announcements

Share price: ₹40.07
Market cap: ₹307.1 Cr
Revenue (annual): ₹202.3 Cr
Net profit (annual): ₹17.80 Cr
P/E (TTM): 22.6×Sector 47.4×
Promoter holding: 31.36%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 3 Debt & Borrowing 2 Board Meeting Date 2 Annual General Meeting 2 Results Update 1 Price Movement Clarification 1 Other Announcement 1 Capacity Expansion 1 Business Update 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

27 May 2026 16:22 IST BSE

Other Announcement

Ambalal Sarabhai Enterprises Other Announcement

Ambalal Sarabhai Enterprises submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report details the company's regulatory adherence status.

Read the filing ↗